Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa

被引：79
作者：
Renau, TE
Léger, R
Filonova, L
Flamme, EM
Wang, M
Yen, R
Madsen, D
Griffith, D
Chamberland, S
Dudley, MN
Lee, VJ
Lomovskaya, O
Watkins, WJ
Ohta, T
Nakayama, K
Ishida, Y
机构：
[1] Essential Therapeut Inc, Mountain View, CA 94043 USA
[2] Daiichi Pharmaceut Co Ltd, New Prod Res Labs 1, Tokyo 1348630, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 16期
关键词：
D O I：
10.1016/S0960-894X(03)00556-0
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Conformational restriction of the ornithine residue of the efflux pump inhibitor D-ornithine-D-homophenylalanine-3-aminoquinoline (MC-02 595 2) furnished bioisosteric proline derivatives that were less toxic in vivo and as active as the lead in potentiating the activity of the fluoroquinolone levofloxacin via the inhibition of efflux pumps in Pseudomonas aeruginosa. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2755 / 2758
页数：4
相关论文
共 8 条
  • [1] GRIFFITH D, 2001, 41 INT C ANT AG CHEM
  • [2] Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa
    Lomovskaya, O
    Lee, A
    Hoshino, K
    Ishida, H
    Mistry, A
    Warren, MS
    Boyer, E
    Chamberland, S
    Lee, VJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1340 - 1346
  • [3] Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa:: Novel agents for combination therapy
    Lomovskaya, O
    Warren, MS
    Lee, A
    Galazzo, J
    Fronko, R
    Lee, M
    Blais, J
    Cho, D
    Chamberland, S
    Renau, T
    Leger, R
    Hecker, S
    Watkins, W
    Hoshino, K
    Ishida, H
    Lee, VJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 105 - 116
  • [4] Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin
    Renau, TE
    Léger, R
    Flamme, EM
    Sangalang, J
    She, MW
    Yen, R
    Gannon, CL
    Griffith, D
    Chamberland, S
    Lomovskaya, O
    Hecker, SJ
    Lee, VJ
    Ohta, T
    Nakayama, K
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) : 4928 - 4931
  • [5] Efflux pump inhibitors to address bacterial and fungal resistance
    Renau, TE
    Lemoine, RC
    [J]. DRUGS OF THE FUTURE, 2001, 26 (12) : 1171 - 1178
  • [6] Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa
    Renau, TE
    Léger, R
    Yen, R
    She, MW
    Flamme, EM
    Sangalang, J
    Gannon, CL
    Chamberland, S
    Lomovskaya, O
    Lee, VJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) : 763 - 766
  • [7] Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa
    Renau, TE
    Léger, R
    Flamme, EM
    She, MW
    Gannon, CL
    Mathias, KM
    Lomovskaya, O
    Chamberland, S
    Lee, VJ
    Ohta, T
    Nakayama, K
    Ishida, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (05) : 663 - 667
  • [8] CONFORMATIONALLY RESTRICTED ARGININE ANALOGS
    WEBB, TR
    EIGENBROT, C
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (09) : 3009 - 3016
1